Form D · Biotechnology
ClearNote Health, Inc.
San Diego, CA · CIK 0001865556
Offering snapshot reported Jun 5, 2025 · SEC filing
- Reported sold
- $21.8M Offering amount: $60.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 5, 2025 | Initial | $21,784,827 | No comparison | 5 | SEC filing |
| Jun 21, 2021 | Initial | $69,321,211 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548171
Offering of Series D Preferred Stock and Series D-1 Preferred Stock (collectively "Series D"), warrants to purchase Series D and the underlying shares of Common Stock issuable upon conversion of Series D.
Source: Form D, filed Jun 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Levy | Executive |
| David Mullarkey | Director, Executive |
| Tina Nova | Director |
| Stephen Quake | Director |
| Johan Mattias Westerman | Director |
| Johan Mattias Westman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10578 Science Center Drive Suite 210
San Diego, CA, 92121
San Diego, CA, 92121